Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07052578Recruiting
Study of Genetic Markers in High-Risk Metastatic Prostate Cancer
This study looks at men with advanced prostate cancer that has spread and is still responding to hormone therapy. It collects blood samples to check for genetic changes that might influence treatment, aiming to improve understanding of aggressive disease.
ArkhangelskAges 18 years+ - NCT07889388Recruiting
Glucose monitor for pregnant women with diabetes
This study tests a new continuous glucose monitor (a small sensor that tracks blood sugar) worn on both arms during pregnancy. It aims to help manage blood sugar levels in pregnant women with type 1, type 2, or gestational diabetes, potentially improving outcomes for mother and baby.
Ulm, Baden-WurttembergAges 18 years+ - NCT07890714RecruitingPhase 1/Phase 2
A new treatment for solid tumors that have spread
This study tests a new drug called Dato-DXd in people with various solid tumors. It may help shrink tumors or slow their growth.
TaichungAges 18 years+ - NCT07890311Enrolling by invitationPhase 2
Study of vedotin for advanced bile duct cancer after first treatment
This trial tests a new drug called vedotin for people with advanced bile duct or gallbladder cancer that has grown after at least one prior treatment. The drug is given as an infusion and works by targeting cancer cells with a specific marker, potentially slowing or shrinking the tumor.
Jiangmen, GuangdongAges 18–80 - NCT07600723RecruitingPhase 4
Study of sotatercept for pulmonary arterial hypertension
This study tests a new treatment called sotatercept for people with pulmonary arterial hypertension (PAH), a condition where the blood vessels in the lungs are narrow, making the heart work harder. The goal is to see if this medicine can help improve symptoms and daily function.
Belagavi, KarnatakaAges 18 years+ - NCT07245186Enrolling by invitation
Healthy living program for kidney decline
This study tests a program to help people with chronic kidney disease (CKD) stay healthy through diet tracking and other proactive steps. It focuses on people whose kidney function has declined but who are not yet on dialysis.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT06692140Recruiting
Comparing two types of stents for heart artery treatment
This trial compares a newer type of stent (with very thin struts and a coating that dissolves) to a standard stent in people having a heart artery procedure. It aims to see if the new stent works as well or better.
AalborgAges 18 years+ - NCT06769698RecruitingPhase 2
Testing fianlimab with cemiplimab for head and neck cancer
This study compares a new combination of two drugs (fianlimab and cemiplimab) against cemiplimab alone for people with head and neck cancer that has returned or spread. It aims to see if the combination works better.
Los Angeles, CaliforniaAges 18 years+ - NCT07567053Recruiting
Transcranial magnetic stimulation for movement in cerebral palsy
This study uses a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) to try to improve motor function in children and young adults with cerebral palsy. It also uses EEG to measure brain activity to understand how the brain changes.
Fort Worth, TexasAges 6–20 - NCT05534672RecruitingPhase 3
Rapamycin for drug-resistant seizures in tuberous sclerosis
This trial tests whether rapamycin (compared with a placebo) can reduce seizures caused by tuberous sclerosis complex (TSC) that have not been controlled by usual medicines. If you qualify, you may be helping doctors find a safer and more effective option for seizure control.
LodzAges 3 months–50 years - NCT07222488RecruitingPhase 1/Phase 2
Study of MK-3120 for bladder cancer
This trial tests a new drug, MK-3120, for people with a specific type of bladder cancer that hasn't spread into the muscle. It is for patients who either haven't had BCG treatment before or have had BCG treatment and their cancer came back more than 12 months but within 2 years after the last dose.
Bakersfield, CaliforniaAges 18 years+ - NCT07827599RecruitingPhase 3
Flu prevention pill for household contacts
This trial tests whether a single dose of an antiviral medicine (baloxavir marboxil) can prevent the flu in people who live with someone who has the flu. It's designed for household contacts who are not yet sick but have been exposed.
Guangzhou, GuangdongAges 5 years+ - NCT07071519RecruitingPhase 3
Risankizumab for young people with ulcerative colitis
This study tests risankizumab (a medication that targets inflammation) in young people with ulcerative colitis who haven't improved enough on other treatments. It aims to see if risankizumab can help control symptoms and reduce bowel inflammation.
Phoenix, ArizonaAges 2–17 - NCT07080905RecruitingPhase 3
Gene therapy for teens with severe hemophilia B
This study tests a new one-time gene therapy (CSL222) in teenage boys with severe hemophilia B. The goal is to see if a single dose can help their bodies produce factor IX, potentially reducing or stopping the need for regular infusions.
Orange, CaliforniaAges 11.5 years–17.2 years - NCT07879638Recruiting
Can e-cigarettes with flavor options help smokers quit?
This study tests whether having more flavor choices in e-cigarettes helps people who smoke cigarettes quit. If you join, you'll use an e-cigarette and answer questions on a smartphone app.
Fort Lauderdale, FloridaAges 21–65 - NCT07637539Recruiting
Brief alcohol advice for hospital patients with liver risk
This study tests a brief alcohol intervention for people who are hospitalized and may have liver damage from drinking. It aims to help reduce alcohol use and improve liver health, and it might be a good time to make a change while you're already in the hospital.
BergenAges 18 years+ - NCT04657068RecruitingPhase 1/Phase 2
Study of ART0380 for advanced solid tumors
This study tests a new drug called ART0380 for people with advanced solid tumors that have not responded to standard treatments. It may be especially helpful for those with certain DNA repair gene changes (like ATM or BRCA). The drug will be given alone or with chemotherapy (gemcitabine or irinotecan) depending on the part of the trial.
Birmingham, AlabamaAges 18 years+ - NCT06052826RecruitingPhase 2
Geriatric support to speed recovery after CAR-T for older adults
This study tests whether extra geriatric support before and after CAR-T cell therapy helps people 60 and older recover faster. It is for patients with B-cell non-Hodgkin lymphoma or multiple myeloma who are scheduled for an FDA-approved CAR-T treatment.
Duarte, CaliforniaAges 60 years+ - NCT07566624Recruiting
Registry study of Hydra heart valve replacement procedure
This study tracks patients who receive a Hydra artificial heart valve to replace a severely narrowed aortic valve. Researchers will follow your progress to understand how well the device works and its safety in real-world use.
BarcelonaAges 18 years+ - NCT05440708RecruitingPhase 1/Phase 2
Study drug for advanced liver cancer that cannot be removed
This trial tests TTI-101, by itself and with other cancer medicines, for liver cancer that is advanced and cannot be removed by surgery. It aims to see whether the treatment can slow the cancer down and improve outcomes.
Birmingham, AlabamaAges 18 years+ - NCT05896306Recruiting
Monitor blood flow in newborns during resuscitation
This study uses a painless light-based monitor to track how blood is moving in the brains of newborns during resuscitation. It may help doctors better understand what’s happening during care for very sick newborns.
Graz, StyriaAges birth–15 minutes - NCT07003425RecruitingPhase 2
Long-term safety and effectiveness of APG777 for eczema
This study looks at the long-term safety and how well APG777 works for people with eczema (atopic dermatitis). It is for people who have already completed treatment with APG777 in an earlier study and may benefit from continuing it.
Fountain Valley, CaliforniaAges 18 years+ - NCT05566002Recruiting
AI review of test results for pulmonary hypertension
This trial uses an artificial intelligence tool to look at results from tests used to evaluate pulmonary hypertension. It may help doctors make sense of your past test results, especially heart and lung evaluation results.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05484973Recruiting
Portable scalp cooling to help prevent chemotherapy hair loss
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
Tucson, ArizonaAges 21 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.